A drug that could simplify pill-taking for many Americans with the most common form of diabetes has shown promise in clinical trials, researchers report. The drug is muraglitazar, which mounts a two-pronged attack against high blood sugar and high cholesterol, the major problems faced by people with type 2 diabetes, in which the body gradually loses its ability to metabolize insulin."Further, muraglitazar achieved these goals with only one pill a day, which makes it easier for people with type 2 diabetes to manage multiple health problems and may enhance patient compliance,” Dr. David Kendall, medical director of the International Diabetes Center in Minneapolis, said in a statement.Kendall was to present the findings Sunday at the American Diabetes Association’s annual meeting in San Diego.
